-
1.发明授权Process for the hydroformulation of olefinically unsaturated organic reactants using a supported aqueous phase catalyst 失效使用负载型水相催化剂对烯属不饱和有机反应物进行加氢成型的方法
公开(公告)号：US4947003A
公开(公告)日：1990-08-07
申请号：US276730
申请日：1988-11-28
申请人： Mark E. Davis , Juan P. Arhancet , Brian E. Hanson
发明人： Mark E. Davis , Juan P. Arhancet , Brian E. Hanson
CPC分类号： B01J31/1616 , B01J31/24 , B01J31/2404 , C07C45/49 , C07C45/50 , B01J2231/321 , B01J2531/822 , B01J2531/96 , Y02P20/588
摘要： A process for the hydroformylation of alkenes and other olefinically unsaturated reactants by reaction with carbon monoxide and hydrogen in the presence of a heterogeneous catalyst comprising a solid surface having immobilized thereon a solution of one or more rhodium complexes which is essentially immiscible with the organic reactant. Catalyst is subsequently recovered from the resulting hydroformylation product by one or more solid-liquid separation techniques.
摘要翻译： 在非均相催化剂存在下，通过与一氧化碳和氢气反应来进行烯烃和其它烯属不饱和反应物的加氢甲酰化的方法，所述非均相催化剂包括其上固定有一种或多种与有机反应物不混溶的铑络合物的溶液的固体表面。 随后通过一种或多种固液分离技术从所得加氢甲酰化产物中回收催化剂。
-
2.发明授权Supported aqueous phase organometallic catalyst useful for hydroformylation and other reactions, and a method for its preparation 失效用于加氢甲酰化和其他反应的支持的水相有机金属催化剂及其制备方法
公开(公告)号：US4994427A
公开(公告)日：1991-02-19
申请号：US276825
申请日：1988-11-28
申请人： Mark E. Davis , Juan P. Arhancet , Brian E. Hanson
发明人： Mark E. Davis , Juan P. Arhancet , Brian E. Hanson
CPC分类号： B01J31/2404 , B01J31/1616 , B01J31/24 , C07C45/49 , C07C45/50 , B01J21/08 , B01J2231/321 , B01J2531/822 , B01J2531/96 , Y02P20/588
摘要： This invention relates to a catalyst comprising a solid surface having immobilized thereon an aqueous solution of one or more organic complexes of rhodium. The catalyst is useful for promoting hydroformylation, hydrogenation and other chemical reactions in essentially water-immiscible organic liquid reactant phases.
摘要翻译： 本发明涉及一种催化剂，其包含在其上固定有一种或多种铑有机配合物的水溶液的固体表面。 该催化剂可用于在基本上与水不混溶的有机液体反应物相中促进加氢甲酰化，氢化和其它化学反应。
-
公开(公告)号：US09313752B2
公开(公告)日：2016-04-12
申请号：US12123851
申请日：2008-05-20
申请人： Stanislaw Czaja , Mark E. Davis , Anthony Lee , Sang Gook Kim , Li-Hsiang Sun
发明人： Stanislaw Czaja , Mark E. Davis , Anthony Lee , Sang Gook Kim , Li-Hsiang Sun
CPC分类号： H04W52/343
摘要： Automatic provisioning of an access point base station or femtocell. The method may include the femtocell transmitting first information (e.g., location information, signal measurement information, capability information, etc.) to a service provider (e.g., over an IP network). The femtocell may receive second information from the service provider, where the second information includes one or more operational parameters. The operational parameters may include hand-off parameters, admission policy parameters, PN or scrambling codes, power parameters, and/or other parameters. The femtocell may operate according to the received parameters to provide access for a plurality of access terminals in a local area.
摘要翻译： 自动提供接入点基站或毫微微小区。 该方法可以包括毫微微小区向服务提供商（例如，通过IP网络）发送第一信息（例如，位置信息，信号测量信息，能力信息等）。 毫微微小区可以从服务提供商接收第二信息，其中第二信息包括一个或多个操作参数。 操作参数可以包括切换参数，准入策略参数，PN或扰码，功率参数和/或其他参数。 毫微微小区可以根据所接收的参数进行操作，以便为局域中的多个接入终端提供接入。
-
4.发明申请公开(公告)号：US20140199370A1
公开(公告)日：2014-07-17
申请号：US13968112
申请日：2013-08-15
IPC分类号： A61K47/48
CPC分类号： A61K47/645 , A61K9/0014 , A61K9/0019 , A61K47/34 , A61K47/40 , A61K47/59 , A61K47/60 , A61K47/61 , A61K47/6951 , A61L15/28 , A61L15/44 , A61L26/0023 , A61L26/0066 , A61L2300/252 , A61L2300/258 , A61L2300/622 , A61L2300/626 , A61L2300/802 , B82Y5/00 , C08L5/16
摘要： This application discloses cyclodextrin-modified materials for carrying drugs and other active agents, such as nucleic acids. Compositions are also disclosed of cyclodextrin-modified materials that release such active agents under controlled conditions. The invention also discloses compositions of cyclodextrin-modified polymer carriers that are coupled to biorecognition molecules for assisting the delivery of drugs to their site of action.
摘要翻译： 本申请公开了用于携带药物和其它活性剂如核酸的环糊精改性物质。 还公开了在控制条件下释放这种活性剂的环糊精改性物质的组合物。 本发明还公开了环糊精改性聚合物载体的组合物，其与生物识别分子偶联以辅助将药物递送至其作用位点。
-
公开(公告)号：US08729256B2
公开(公告)日：2014-05-20
申请号：US13007389
申请日：2011-01-14
CPC分类号： C07H1/00 , C07D307/58 , C07H3/02
摘要： Disclosed are processes for isomerizing saccharides. Also disclosed are processes for converting saccharides to furan derivatives. Also disclosed are processes for converting starch to furan derivatives.
摘要翻译： 公开了异构化糖的方法。 还公开了将糖转化成呋喃衍生物的方法。 还公开了将淀粉转化为呋喃衍生物的方法。
-
公开(公告)号：US20130288986A1
公开(公告)日：2013-10-31
申请号：US13922739
申请日：2013-06-20
申请人： Mark E. Davis , Jungyeon Hwang , Tianyi Ke , Ching-jou Lim , Thomas Schluep
发明人： Mark E. Davis , Jungyeon Hwang , Tianyi Ke , Ching-jou Lim , Thomas Schluep
IPC分类号： A61K47/48
CPC分类号： A61K47/61 , A61K47/65 , A61K47/6939 , A61K47/6951 , B82Y5/00
摘要： Described herein is a cyclodextrin containing polymer conjugate.
摘要翻译： 本文描述的是含有环糊精的聚合物缀合物。
-
公开(公告)号：US08497365B2
公开(公告)日：2013-07-30
申请号：US13198403
申请日：2011-08-04
申请人： Mark E. Davis , Jungyeon Hwang , Tianyi Ke , Ching-Jou Lim , Thomas Schluep
发明人： Mark E. Davis , Jungyeon Hwang , Tianyi Ke , Ching-Jou Lim , Thomas Schluep
IPC分类号： B82Y5/00
CPC分类号： A61K47/61 , A61K47/65 , A61K47/6939 , A61K47/6951 , B82Y5/00
摘要： The present invention relates to novel compositions comprising polymeric moieties covalently attached to therapeutic agents, wherein the therapeutic agent is attached to the polymeric moiety through a tether. By selecting from a variety of tether groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein.
摘要翻译： 本发明涉及包含与治疗剂共价连接的聚合物部分的新型组合物，其中治疗剂通过系链连接到聚合物部分。 通过从各种系链组和靶向配体中选择，聚合物呈现用于治疗剂的受控递送的方法。 本发明还涉及用本文所述的治疗组合物治疗受试者的方法。
-
公开(公告)号：US08399431B2
公开(公告)日：2013-03-19
申请号：US13553376
申请日：2012-07-19
申请人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
发明人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
IPC分类号： A61K31/337 , A61K31/4745 , C08G2/30 , C08G69/08 , C08G69/10 , C08L5/16
CPC分类号： C08G69/44 , A61K31/337 , A61K31/7048 , A61K47/48176 , A61K47/48192 , A61K47/482 , A61K47/48215 , A61K47/4823 , A61K47/48338 , A61K47/48969 , A61K47/58 , A61K47/59 , A61K47/60 , A61K47/61 , A61K47/6951 , B82Y5/00 , C08B30/00 , C08B31/00 , C08B37/0012 , C08F220/28 , C08F220/58 , C08F222/22 , C08F2220/282 , C08G81/02 , G06F19/00 , G06F19/3456 , G06Q50/22 , Y02A90/22 , Y02A90/26
摘要： The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein.
-
公开(公告)号：US08314230B2
公开(公告)日：2012-11-20
申请号：US13277780
申请日：2011-10-20
申请人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
发明人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
CPC分类号： C08G69/44 , A61K31/337 , A61K31/7048 , A61K47/48176 , A61K47/48192 , A61K47/482 , A61K47/48215 , A61K47/4823 , A61K47/48338 , A61K47/48969 , A61K47/58 , A61K47/59 , A61K47/60 , A61K47/61 , A61K47/6951 , B82Y5/00 , C08B30/00 , C08B31/00 , C08B37/0012 , C08F220/28 , C08F220/58 , C08F222/22 , C08F2220/282 , C08G81/02 , G06F19/00 , G06F19/3456 , G06Q50/22 , Y02A90/22 , Y02A90/26
摘要： The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein.
-
公开(公告)号：US20120289480A1
公开(公告)日：2012-11-15
申请号：US13553400
申请日：2012-07-19
申请人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
发明人： Jianjun Cheng , Mark E. Davis , Kay T. Khin
IPC分类号： A61K31/724 , C08B37/16
CPC分类号： C08G69/44 , A61K31/337 , A61K31/7048 , A61K47/48176 , A61K47/48192 , A61K47/482 , A61K47/48215 , A61K47/4823 , A61K47/48338 , A61K47/48969 , A61K47/58 , A61K47/59 , A61K47/60 , A61K47/61 , A61K47/6951 , B82Y5/00 , C08B30/00 , C08B31/00 , C08B37/0012 , C08F220/28 , C08F220/58 , C08F222/22 , C08F2220/282 , C08G81/02 , G06F19/00 , G06F19/3456 , G06Q50/22 , Y02A90/22 , Y02A90/26
摘要： The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein.
-
-
-
-
-
-
-
-
-
搜索结果
169 条记录 (耗时 0.054 秒)
